FDA — authorised 24 July 1964
- Status: approved
🇺🇸 Trisoralen in United States
FDA authorised Trisoralen on 24 July 1964
Marketing authorisations
FDA — authorised 24 July 1964
- Application: NDA012697
- Marketing authorisation holder: VALEANT PHARM INTL
- Local brand name: TRISORALEN
- Indication: TABLET — ORAL
- Status: approved
Trisoralen in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Dermatology approved in United States
Frequently asked questions
Is Trisoralen approved in United States?
Yes. FDA authorised it on 24 July 1964; FDA authorised it on 24 July 1964.
Who is the marketing authorisation holder for Trisoralen in United States?
Marketing authorisation holder not available in our data.